MIRA Pharmaceuticals, Inc. Common Stock (MIRA) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - GENERAL

Exchange: NASDAQ

Key Metrics

• Price: $1.33
• Market Cap: $53.18M
• EPS: $-1.60
• 52-Week High: $2.45
• 52-Week Low: $0.73

Market Sentiment

MIRA Pharmaceuticals, Inc. Common Stock currently has a Bullish sentiment score of 0.34.

About MIRA Pharmaceuticals, Inc. Common Stock

MIRA Pharmaceuticals, Inc. is a clinical development stage biopharmaceutical company based in Baltimore, Maryland, specializing in the advancement of innovative therapies for unmet medical needs. With a robust pipeline of proprietary drug candidates undergoing rigorous clinical trials, MIRA aims to enhance treatment outcomes across various therapeutic areas. The company's strong commitment to research and development, coupled with its potential to disrupt the biopharmaceutical landscape, posi...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for MIRA Pharmaceuticals, Inc. Common Stock and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does MIRA pay dividends?

MIRA Pharmaceuticals, Inc. Common Stock (MIRA) does not currently pay a regular dividend.

What is MIRA's market cap?

MIRA Pharmaceuticals, Inc. Common Stock (MIRA) has a market capitalization of $53.18M with a current stock price of $1.33.